Screening for drugs potentially interfering with MCT8-mediated T3 transport in vitro identifies dexamethasone and some commonly used drugs as inhibitors of MCT8 activity
Authors:
- 30 November 2021
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 45 (4) , 803-814
Abstract
Background Monocarboxylate transporter 8 (MCT8) is the first thyroid hormone transporter that has been linked to a human disease. Besides genetic alterations other factors might impair MCT8 activity. Aim This study aimed at investigating whether some common drugs having a structural similarity with TH and/or whose treatment is associated with thyroid function test abnormalities, or which behave as antagonists of TH action can inhibit MCT8-mediated T3 transport. Methods [125I]T3 uptake and efflux were measured in COS-7 cells transiently transfected with hMCT8 before and after exposure to increasing concentrations of hydrocortisone, dexamethasone, prednisone, prednisolone, amiodarone, desethylamiodarone, dronedarone, buspirone, carbamazepine, valproic acid, and l-carnitine. The mode of inhibition was also determined. Results Dexamethasone significantly inhibited T3 uptake at 10 μM; hydrocortisone reduced T3 uptake only at high concentrations, i.e. at 500 and 1000 μM; prednisone and prednisolone were devoid of inhibitory potential. Amiodarone caused a reduction of T3 uptake by MCT8 only at the highest concentrations used (44% at 50 μM and 68% at 100 μM), and this effect was weaker than that produced by desethylamiodarone and dronedarone; buspirone resulted a potent inhibitor, reducing T3 uptake at 0.1–10 μM. l-Carnitine inhibited T3 uptake only at 500 mM and 1 M. Kinetic experiments revealed a noncompetitive mode of inhibition for all compounds. All drugs inhibiting T3 uptake did not affect T3 release. Conclusion This study shows a novel effect of some common drugs, which is inhibition of T3 transport mediated by MCT8. Specifically, dexamethasone, buspirone, desethylamiodarone, and dronedarone behave as potent inhibitors of MCT8.Keywords
This publication has 58 references indexed in Scilit:
- Exogenous glucocorticoids and adverse cerebral effects in childrenEuropean Journal of Paediatric Neurology, 2011
- Essential Molecular Determinants for Thyroid Hormone Transport and First Structural Implications for Monocarboxylate Transporter 8Journal of Biological Chemistry, 2010
- Neurodevelopmental and Neurophysiological Actions of Thyroid HormoneJournal of Neuroendocrinology, 2008
- Outcomes at 2 Years of Age after Repeat Doses of Antenatal CorticosteroidsNew England Journal of Medicine, 2007
- Effect of amiodarone and dronedarone administration in rats on thyroid hormone-dependent gene expression in different cardiac componentsEuropean Journal of Endocrinology, 2007
- Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurityAmerican Journal of Obstetrics and Gynecology, 2004
- Effect of mutations in the β1‐thyroid hormone receptor on the inhibition of T3 binding by desethylamiodaroneFEBS Letters, 1999
- Pharmacokinetics and Oral Bioavailability of HydrocortisoneThe Journal of Clinical Pharmacology, 1991
- Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells.Journal of Clinical Investigation, 1989
- Amiodarone pharmacokineticsAmerican Heart Journal, 1983